These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 207172)

  • 1. Regulation of phospholipase activity in platelets.
    Lapetina EG; Schmitges CJ; Chandrabose K; Cuatrecasas P
    Adv Prostaglandin Thromboxane Res; 1978; 3():127-35. PubMed ID: 207172
    [No Abstract]   [Full Text] [Related]  

  • 2. Phospholipase A2 and platelet aggregation.
    Blackwell GJ
    Adv Prostaglandin Thromboxane Res; 1978; 3():137-42. PubMed ID: 655004
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic adenosine 3',5'-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets.
    Lapetina EG; Schmitges CJ; Chandrabose K; Cuatrecases P
    Biochem Biophys Res Commun; 1977 Jun; 76(3):828-35. PubMed ID: 197928
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
    Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
    Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
    [No Abstract]   [Full Text] [Related]  

  • 6. Contribution of arachidonic acid metabolites to atherosclerosis.
    Dembińska-Kieć A; Gryglewski RJ
    Wien Klin Wochenschr; 1986 Apr; 98(7):198-206. PubMed ID: 3010578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium inhibits adenylate cyclase of human platelets.
    Imandt L; Tijhuis D; Wessels H; Haanen C
    Thromb Haemost; 1981 Apr; 45(2):142-5. PubMed ID: 6266068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of prostaglandins in platelet function.
    Burch JW; Majerus PW
    Semin Hematol; 1979 Jul; 16(3):196-207. PubMed ID: 113883
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel prostaglandin endoperoxide analogs having prostacyclin-like actions on platelets from human and horse but not from rat and rabbit.
    Wilson NH; Armstrong RA; Jones RL
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():491-5. PubMed ID: 2821762
    [No Abstract]   [Full Text] [Related]  

  • 13. A new anti-platelet drug, E5510, has multiple suppressive sites during receptor-mediated signal transduction in human platelets.
    Fujimori T; Harada K; Saeki T; Kogushi M; Yoshimura T; Katayama K
    Jpn J Pharmacol; 1991 Jan; 55(1):81-91. PubMed ID: 1645815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of phospholipase C in platelet responses.
    Lapetina EG; Siess W
    Life Sci; 1983 Sep; 33(11):1011-8. PubMed ID: 6412009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids.
    Lagarde M; Guichardant M; Ghazi I; Dechavanne M
    Prostaglandins; 1980 Apr; 19(4):551-7. PubMed ID: 7384555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of action of antiplatelet medication].
    Navarro JL; Frade FJ; Alava I; Obispo T; Trejo R; Jiménez C; Cesar J
    Sangre (Barc); 1984; 29(4-C):817-32. PubMed ID: 6096974
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanism of platelet aggregation inhibition].
    Abiko Y; Ashida S
    Rinsho Byori; 1979; Suppl 40():169-80. PubMed ID: 233105
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of diamide (azodicarboxylic acid-bis-dimethylamide) on arachidonic acid release from human blood platelet phospholipids.
    Lösche W; Michel E; Thielmann K; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):769-73. PubMed ID: 6083952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.